“eConsent is a technology-driven, patient-engagement tool that aims to improve site/patient discussions and clinical trial efficiency. It should provide a detailed overview of the clinical trial process in the patient’s own language, while including guided instructions for completing the eConsent and allowing the patient to electronically sign and optionally download the signed consent document. This helps to promote better comprehension of content by incorporating multi-media components like audio and video, or documents with voice-overs in the patient’s own language. The process allows patients to explore trial-specific words and concepts at their own pace through linked text, which can improve the quality of discussions between site staff and patients in a less intimidating way.”
Read more from the guest blog post: eConsent – A More Reliable Way to Consent Patients Into a Clinical Trial? written by Neil Vivian, senior director of Business Solutions at OmniComm Systems, Inc. for Xtalks, a leading provider of educational webinars to the global life science, food and medical device community.
Learn about best practices for managing traditional patient consent and using electronic data capture (EDC) and eConsent as alternative strategies.
Join Jacquie Mardell, vice president of Clinical Operations at Ascendis Pharma, and Neil Vivian, senior director of Business Solutions at OmniComm Systems, Inc., (photo) in a live webinar on Thursday, April 18, 2019 at 11 a.m., ET (4 p.m. BST/UK). For more information or to register for this event, visit Patient Consent – Trials and Tribulations of the Traditional Approach. Can eConsent Deliver an Improved Method?